NCT04820010View on ClinicalTrials.gov

Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

November 1, 2020

Study Completion Date

November 1, 2020

Conditions
Corneal UlcerCorneal PerforationCorneal Epithelium DefectNeurotrophic Keratitis
Interventions
DRUG

Topical Insulin

Patients were administered eyedrops enriched with insulin

Trial Locations (1)

Unknown

Centro Hospitalar Vila Nova de Gaia e Espinho, Vila Nova de Gaia

All Listed Sponsors
lead

Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.

OTHER_GOV

NCT04820010 - Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3 | Biotech Hunter | Biotech Hunter